SHIRIN NOORANI: Open Payments
NPI 1568865947 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,327 in 64 payments from 13 companies in 2025. Trend: 2023 $1,314 · 2024 $1,244 · 2025 $1,327
Food & beverage: $1,159Education: $168
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $256 |
| Regeneron Healthcare Solutions, Inc. | 11 | $192 |
| Galderma Laboratories, L.P. | 8 | $158 |
| Novartis Pharmaceuticals Corporation | 10 | $152 |
| Janssen Biotech, Inc. | 10 | $138 |
| GlaxoSmithKline, LLC. | 4 | $94 |
| E.R. Squibb & Sons, L.L.C. | 1 | $85 |
| ABBVIE INC. | 2 | $56 |
| UCB, Inc. | 3 | $55 |
| Verona Pharma, Inc. | 2 | $55 |
Products named: DUPIXENT, NEMLUVIO, COSENTYX, TREMFYA, LIBTAYO, TRELEGY ELLIPTA, Sotyktu, Bimzelx.
Industry payments across GA — which companies pay providers there.
